Vaineau Romain, Jeger-Madiot Raphaël, Ali-Moussa Samir, Prudhomme Laura, Debarnot Hippolyte, Coatnoan Nicolas, Dubois Johanna, Binvignat Marie, Vantomme Hélène, Gouritin Bruno, Fourcade Gwladys, Engeroff Paul, Belbézier Aude, Luscan Romain, Denoyelle Françoise, Lorenzon Roberta, Ribet Claire, Rosenzwajg Michelle, Bellier Bertrand, Klatzmann David, Tchitchek Nicolas, Graff-Dubois Stéphanie
Immunology, Immunopathology, Immunotherapy, INSERM U959, Pitié Salpétrière Hospital, Sorbonne University, Paris, France.
AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.
JCI Insight. 2025 May 20;10(12). doi: 10.1172/jci.insight.188724. eCollection 2025 Jun 23.
Dysregulation of T follicular helper (Tfh) and T follicular regulatory (Tfr) cell homeostasis in germinal centers (GCs) can lead to antibody-mediated autoimmunity. While IL-1β modulates the GC response via IL-1R1 and IL-1R2 receptors on follicular T cells in animal models, its role in humans remains unclear. We analyzed Tfh and Tfr phenotypes in human secondary lymphoid organs (tonsils, spleen, and mesenteric lymph nodes) using flow cytometry, single-cell transcriptomics, and in vitro culture, comparing findings with samples from autoimmune patients. We observed organ-specific Tfh/Tfr phenotypes according to activation status and IL-1 receptor expression. An excess of IL-1R1 over IL-1R2 expression promoted a unique activated Tfr subset with Treg and GC-Tfh features. IL-1β signaling via IL-1R1 enhanced follicular T cell activation and Tfh-to-Tfr differentiation, while IL-1β inhibition upregulated IL-1R1, indicating a tightly regulated process. In autoimmune patients, high IL-1β and circulating Tfr levels correlated with increased autoantibody production, linking inflammation, IL-1β signaling, and Tfr/Tfh balance. Our findings highlight the critical role of IL-1β in follicular T cell activation and suggest that targeting IL-1β signaling in Tfh and Tfr cells could be a promising strategy for treating antibody-mediated autoimmune diseases.
生发中心(GC)中滤泡辅助性T细胞(Tfh)和滤泡调节性T细胞(Tfr)的稳态失调可导致抗体介导的自身免疫。虽然在动物模型中,白细胞介素-1β(IL-1β)通过滤泡T细胞上的IL-1R1和IL-1R2受体调节GC反应,但其在人类中的作用仍不清楚。我们使用流式细胞术、单细胞转录组学和体外培养分析了人类二级淋巴器官(扁桃体、脾脏和肠系膜淋巴结)中的Tfh和Tfr表型,并将结果与自身免疫患者的样本进行比较。我们根据激活状态和IL-1受体表达观察到了器官特异性的Tfh/Tfr表型。IL-1R1表达超过IL-1R2会促进一个具有调节性T细胞(Treg)和GC-Tfh特征的独特活化Tfr亚群。通过IL-1R1的IL-1β信号增强了滤泡T细胞的活化和Tfh向Tfr的分化,而IL-1β抑制则上调了IL-1R1,表明这是一个严格调控的过程。在自身免疫患者中,高IL-1β水平和循环Tfr水平与自身抗体产生增加相关,将炎症、IL-1β信号和Tfr/Tfh平衡联系起来。我们的研究结果突出了IL-1β在滤泡T细胞活化中的关键作用,并表明靶向Tfh和Tfr细胞中的IL-1β信号可能是治疗抗体介导的自身免疫性疾病的一种有前景的策略。